Skip to main content
SpringerLink
Log in

Targeted and systemic radiotherapy in the treatment of bone metastasis

  • Published:
Cancer and Metastasis Reviews Aims and scope Submit manuscript

Abstract

Cancer metastasis to the bone develops commonly in patients with a variety of malignancies, and is a major cause of morbidity and diminished quality of life in a significant proportion of cancer patients. The effective treatment of bone metastasis requires cooperation between medical, surgical and radiation oncologists. Radiotherapy, either in the form of targeted external beam radiation therapy, or systemic administration of radionuclides, plays a central role in treatment of symptomatic bone metastases. The appropriate external beam treatment techniques, dose and fractionation regimens for the treatment of symptomatic, localized bone metastasis have been established in prospective clinical trials. Large-field, hemi-body irradiation has been utilized for treatment of symptoms related to more widely disseminated bone metastases, but has been associated with substantial toxicity. Strontium-89 and Samarium-153 are widely available systemically administered radionuclides that are useful for the treatment of widely disseminated disease, and have largely supplanted the use of hemi-body irradiation. Combined with appropriate medical and surgical interventions, as well as the appropriate use of analgesics, radiotherapy is a well-tolerated and highly effective treatment for the palliation of symptomatic bone metastases.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Plunkett, T. A., & Rubens, R. D. (1999). The biology and management of bone metastases. Critical Reviews in Oncology/Hematology, 31, 89–96.

    Article  PubMed  CAS  Google Scholar 

  2. Tubiana-Hulin, M. (1991). Incidence, prevalence and distribution of bone metastases. Bone, 12(Suppl 1), S9–S10.

    Article  PubMed  Google Scholar 

  3. Foley, K. M. (1985) The treatment of cancer pain. New England Journal of Medicine, 313, 84–95.

    Article  PubMed  CAS  Google Scholar 

  4. Tong, D., Gillick, L., & Hendrickson, F. R. (1982). The palliation of symptomatic osseous metastases: Final results of the Study by the Radiation Therapy Oncology Group. Cancer, 50, 893–899.

    Article  PubMed  CAS  Google Scholar 

  5. Townsend, P. W., Rosenthal, H. G., Smalley, S. R., Cozad, S. C., & Hassanein, R. E. (1994). Impact of postoperative radiation therapy and other perioperative factors on outcome after orthopedic stabilization of impending or pathologic fractures due to metastatic disease. Journal of Clinical Oncology, 12, 2345–2350.

    PubMed  CAS  Google Scholar 

  6. O’Sullivan, B., Davis, A. M., Turcotte, R., Bell, R., Catton, C., Chabot, P., et al. (2002). Preoperative versus postoperative radiotherapy in soft-tissue sarcoma of the limbs: A randomised trial. Lancet, 359, 2235–2241.

    Article  PubMed  Google Scholar 

  7. Vargha, Z. O., Glicksman, A. S., & Boland, J. (1969). Single-dose radiation therapy in the palliation of metastatic disease. Radiology, 93, 1181–1184.

    PubMed  CAS  Google Scholar 

  8. Wu, J. S., Wong, R., Johnston, M., Bezjak, A., & Whelan, T. (2003). Meta-analysis of dose-fractionation radiotherapy trials for the palliation of painful bone metastases. International Journal of Radiation Oncology, Biology, Physics, 55, 594–605.

    Article  PubMed  Google Scholar 

  9. Steenland, E., Leer, J. W., van Houwelingen, H., Post, W. J., van den Hout, W. B., Kievit, J., et al. (1999). The effect of a single fraction compared to multiple fractions on painful bone metastases: A global analysis of the Dutch Bone Metastasis Study. Radiotherapy and Oncology, 52, 101–109.

    Article  PubMed  CAS  Google Scholar 

  10. van der Linden, Y. M., Lok, J. J., Steenland, E., Martijn, H., van Houwelingen, H., Marijnen, C. A., et al. (2004). Single fraction radiotherapy is efficacious: A further analysis of the Dutch Bone Metastasis Study controlling for the influence of retreatment. International Journal of Radiation Oncology, Biology, Physics, 59, 528–537.

    Article  PubMed  Google Scholar 

  11. Bone Pain Trial Working Party (1999). 8 Gy single fraction radiotherapy for the treatment of metastatic skeletal pain: Randomised comparison with a multifraction schedule over 12 months of patient follow-up. Radiotherapy and Oncology, 52, 111–121.

    Google Scholar 

  12. Hartsell, W. F., Scott, C. B., Bruner, D. W., Scarantino, C. W., Ivker, R. A., Roach, M., et al. (2005). Randomized trial of short- versus long-course radiotherapy for palliation of painful bone metastases. Journal of the National Cancer Institute, 97, 798–804.

    Article  PubMed  Google Scholar 

  13. Poulter, C. A., Cosmatos, D., Rubin, P., Urtasun, R., Cooper, J. S., Kuske, R. R., et al. (1992). A report of RTOG 8206: A phase III study of whether the addition of single dose hemibody irradiation to standard fractionated local field irradiation is more effective than local field irradiation alone in the treatment of symptomatic osseous metastases. International Journal of Radiation Oncology, Biology, Physics, 23, 207–214.

    PubMed  CAS  Google Scholar 

  14. Salazar, O. M., Sandhu, T., da Motta, N. W., Escutia, M. A., Lanzos-Gonzales, E., Mouelle-Sone, A., et al. (2001). Fractionated half-body irradiation (HBI) for the rapid palliation of widespread, symptomatic, metastatic bone disease: A randomized Phase III trial of the International Atomic Energy Agency (IAEA). International Journal of Radiation Oncology, Biology, Physics, 50, 765–775.

    Article  PubMed  CAS  Google Scholar 

  15. Blake, G. M., Zivanovic, M. A., McEwan, A. J., & Ackery, D. M. (1986). Sr-89 therapy: Strontium kinetics in disseminated carcinoma of the prostate. European Journal of Nuclear Medicine, 12, 447–454.

    PubMed  CAS  Google Scholar 

  16. Lewington, V. J., McEwan, A. J., Ackery, D. M., Bayly, R. J., Keeling, D. H., Macleod, P. M., et al. (1991). A prospective, randomised double-blind crossover study to examine the efficacy of strontium-89 in pain palliation in patients with advanced prostate cancer metastatic to bone. European Journal of Cancer, 27, 954–958.

    Article  PubMed  CAS  Google Scholar 

  17. Porter, A. T., McEwan, A. J., Powe, J. E., Reid, R., McGowan, D. G., Lukka, H., et al. (1993). Results of a randomized phase-III trial to evaluate the efficacy of strontium-89 adjuvant to local field external beam irradiation in the management of endocrine resistant metastatic prostate cancer. International Journal of Radiation Oncology, Biology, Physics, 25, 805–813.

    PubMed  CAS  Google Scholar 

  18. Buchali, K., Correns, H. J., Schuerer, M., Schnorr, D., Lips, H., & Sydow, K. (1988). Results of a double blind study of 89-strontium therapy of skeletal metastases of prostatic carcinoma. European Journal of Nuclear Medicine, 14, 349–351.

    Article  PubMed  CAS  Google Scholar 

  19. Quilty, P. M., Kirk, D., Bolger, J. J., Dearnaley, D. P., Lewington, V. J., Mason, M. D., et al. (1994). A comparison of the palliative effects of strontium-89 and external beam radiotherapy in metastatic prostate cancer. Radiotherapy and Oncology, 31: 33–40.

    Article  PubMed  CAS  Google Scholar 

  20. Laing, A. H., Ackery, D. M., Bayly, R. J., Buchanan, R. B., Lewington, V. J., & McEwan A. J. (1991). Strontium-89 chloride for pain palliation in prostatic skeletal malignancy. British Journal of Radiology, 64, 816–822.

    Article  PubMed  CAS  Google Scholar 

  21. Serafini, A. N., Houston, S. J., Resche, I., Quick, D. P., Grund, F. M., Ell, P. J., et al. (1998). Palliation of pain associated with metastatic bone cancer using samarium-153 lexidronam: A double-blind placebo-controlled clinical trial. Journal of Clinical Oncology, 16, 1574–1581.

    PubMed  CAS  Google Scholar 

  22. Sartor, O., Reid, R. H., Hoskin, P. J., Quick, D. P., Ell, P. J., Coleman, R.E, et al. (2004). Samarium-153-Lexidronam complex for treatment of painful bone metastases in hormone-refractory prostate cancer. Urology, 63, 940–945.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Radiation Oncology, University of Michigan, UHB2C490 1500 East Medical Center Drive, Ann Arbor, MI, 48109-0010, USA

    Alexander Lin & Michael E. Ray

Authors
  1. Alexander Lin
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Michael E. Ray
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Alexander Lin.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lin, A., Ray, M.E. Targeted and systemic radiotherapy in the treatment of bone metastasis. Cancer Metastasis Rev 25, 669–675 (2006). https://doi.org/10.1007/s10555-006-9025-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10555-006-9025-z

Keywords

Search

Navigation